Enriched circulating and tumor-resident TGF-ß+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs. (2022)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2022.2104426
PubMed Identifier: 35909944
Publication URI: http://europepmc.org/abstract/MED/35909944
Type: Journal Article/Review
Volume: 11
Parent Publication: Oncoimmunology
Issue: 1
ISSN: 2162-4011